ERBB2 and non-small cell lung carcinoma: Mutations in the gene encoding human epidermal growth factor receptor 2 (HER2) is the mutation of exon 20, and these mutations are found in 2%–4% of NSCLC patients, especially women, besides, the patients with HER2 mutations easily appear brain metastases (24).